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Friedreich’s ataxia is a hereditary neurodegenerative disease
caused by reduced expression of mitochondrial frataxin. Frataxin
deficiency causes impairment in respiratory capacity, disruption
of iron homoeostasis and hypersensitivity to oxidants. Although
the redox properties of NAD (NAD+ and NADH) are essential
for energy metabolism, only few results are available concerning
homoeostasis of these nucleotides in frataxin-deficient cells. In the
present study, we show that the malate–aspartate NADH shuttle
is impaired in Saccharomyces cerevisiae frataxin-deficient cells
(yfh1) due to decreased activity of cytosolic and mitochondrial
isoforms of malate dehydrogenase and to complete inactivation
of the mitochondrial aspartate aminotransferase (Aat1). A
considerable decrease in the amount of mitochondrial acetylated
proteins was observed in the yfh1 mutant compared with
wild-type. Aat1 is acetylated in wild-type mitochondria and
deacetylated in yfh1 mitochondria suggesting that inactivation
could be due to this post-translational modification. Mutants
deficient in iron–sulfur cluster assembly or lacking mitochondrial
DNA also showed decreased activity of Aat1, suggesting that
Aat1 inactivation was a secondary phenotype in yfh1 cells.
Interestingly, deletion of the AAT1 gene in a wild-type strain
caused respiratory deficiency and disruption of iron homoeostasis
without any sensitivity to oxidative stress. Our results show that
secondary inactivation of Aat1 contributes to the amplification of
the respiratory defect observed in yfh1 cells. Further implication
of mitochondrial protein deacetylation in the physiology of
frataxin-deficient cells is anticipated.
Key words: frataxin, Friedreich’s ataxia, malate–aspartate NADH
shuttle, mitochondrion, protein acetylation, yeast.
INTRODUCTION
FA (Friedreich’s ataxia) is the most common autosomal recessive
inherited ataxia. It is a slowly progressive neurodegenerative
disease that affects the central and peripheral nervous system.
Other organs can be affected in FA; 60% of patients develop
cardiomyopathy and almost 40% of patients present diabetes or
glucose intolerance [1]. The most common mutation observed in
FA patients is an unstable hyperexpansion of a GAA trinucleotide
repeat in the first intron of the FXN gene that leads to the formation
of a non-usual B-DNA structure and heterochromatin conforma-
tion that causes transcriptional silencing [2,3]. The consequence
is decreased expression of the encoded protein, frataxin [4].
Frataxin is a small mitochondrial matrix protein that participates
in iron–sulfur cluster assembly [5]. Frataxin deficiency induces
a decrease in the activities of iron–sulfur cluster enzymes and in
respiratory capacity, perturbation of cellular iron homoeostasis
and hypersensitivity to oxidants [6]. Therefore major phenotypes
of frataxin deficiency are related to energy metabolism and
antioxidant response. Although pyridine nucleotides NAD
(NAD+ and NADH) and NADP (NADP+ and NADPH) are
electron carriers essential for energy production and defence
against oxidative stress, little is known about the regulation of
their pools in frataxin-deficient cells. We showed previously
that the NADPH/NADP+ ratio was considerably lower in the
yeast Saccharomyces cerevisiae frataxin-deficient mutant (yfh1)
compared with wild-type, which, in addition to the disturbed
glutathione redox status, contributed to the severe oxidative stress
condition observed in yfh1 cells [7]. Another study showed that
the levels of reduced glutathione, ATP, NADPH and NADH were
significantly increased in the heart of transgenic mice ubiquitously
overexpressing frataxin compared with control animals,
indicating enhanced mitochondrial energy conversion and
antioxidant defence capacity with increasing frataxin levels [8].
Besides being an enzymatic oxidoreductase cofactor, NAD+
is the substrate of enzymes that catalyse protein modification
reactions. In particular, the SIRT (sirtuin)-mediated protein
deacetylation and the ADP-ribosylation, catalysed by PARP
[poly(ADP-ribose) polymerase] family, regulate gene expression,
DNA repair, aging, calcium signalling, generation of ROS
(reactive oxygen species) and cell death [9,10]. In yeast, NAD+
biosynthesis involves a de novo pathway from tryptophan and
several salvage pathways from various precursors, such as
nicotinic acid mononucleotide and nicotinamide riboside [11].
NAD+ biosynthesis appears to occur outside the mitochondria
because all enzymes are localized in the cytosol and the nucleus,
with the exception of Bna4, which is a mitochondrial kynurenine
3-mono-oxygenase required for de novo NAD+ synthesis from
kynurenine. This implies that NAD+ must be imported into the
mitochondria. Two mitochondrial NAD+ transporters, Ndt1 and
Ndt2, perform this function [12]. In addition, reducing equivalents
from NADH can be exchanged between the cytosol and the
mitochondria by NADH shuttles, such as the glycerol 3-phosphate
shuttle, the ethanol–acetaldehyde shuttle and the malate–aspartate
shuttle [13,14]. The glycerol 3-phosphate shuttle only oxidizes
cytosolic NADH transferring the electrons directly to the
respiratory chain. This shuttle has two components, the cytosolic
glycerol-3-phosphate dehydrogenase (Gpd1/2) and the inner
mitochondrial membrane glycerol-3-phosphate dehydrogenase
(Gut2). The ethanol–acetaldehyde shuttle is composed of
Abbreviations used: 2D, two-dimensional; DTT, dithiothreitol; FA, Friedreich’s ataxia; G3PDH, glyceraldehyde-3-phosphate dehydrogenase; HA,
haemagglutinin; LDH, lactate dehydrogenase; PHO, phosphate-responsive signalling; PL, pyridoxal; PLP, pyridoxal 5′-phosphate; PM, pyridoxamine;
PN, pyridoxine; ROS, reactive oxygen species; SIRT, sirtuin; TCA, tricarboxylic acid.
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mitochondrial alcohol dehydrogenase (Adh3) that converts
ethanol into acetaldehyde, producing NADH and the cytosolic
isoforms (Adh1/2) that perform the inverse reaction and synthes-
ize NAD+ in the cytosol. Acetaldehyde and ethanol freely diffuse
through mitochondrial membranes. The yeast malate–aspartate
shuttle components include mitochondrial and cytosolic malate
dehydrogenase (Mdh1/2) and aspartate aminotransferase (Aat1/2)
and the mitochondrial aspartate/glutamate exchanger Agc1 [15].
In yeast, sugar metabolism and biomass production (synthesis of
amino acids, nucleic acids and reduced lipids) result in NADH
generation in the cytosol [13,14]. For the most part of cytosolic
NADH, reoxidation to NAD+ takes place in the mitochondria by
the electron transport chain [14]. Under conditions where respir-
ation is repressed, glycerol production provides NAD+ regener-
ation in the cytosol [14]. Therefore NADH shuttles are required
for maintaining the NAD+ /NADH ratios in the mitochondrial and
cytosolic NAD pools. The biological importance of this function
is evident from the calorie restriction-induced lifespan extension
in yeast [16] and by the brain hypomyelination and cortex neuron
abnormalities in Aralar1 (mitochondrial aspartate/glutamate
transporter)-knockout mice [17]. In the present study, we
concentrated on NAD metabolism in the yeast yfh1 mutant.
MATERIALS AND METHODS
Yeast strains and growth conditions
The S. cerevisiae strains used in the present study were
derived from YPH499 cycloheximide-resistant (wild-type;
MATa ura3-52 lys2-801 ade2-101 trp1-63 his3-200 leu2-
1 cyh2); YPH499yfh1 (yfh1::TRP1), YPH499aat1
(aat1::HIS3MX6), YPH499AAT1-HA and YPH499nfs1-14
[18]. To prevent the accumulation of suppressor mutations, the
yfh1 mutant was constructed using the YPH499 yfh1 shuffle
strain [19]. In the shuffle strain, the yfh1 deletion is covered by
pRS318-YFH1, a plasmid containing the CEN, CYH2 and the
YFH1 HindIII genomic fragment. The plasmid was removed
before experiments by counterselection on YPRaf medium (1%
yeast extract, 2% Bacto peptone, 2% raffinose and 0.1%
glucose) containing 10 μg/ml cycloheximide, which is toxic in
the presence of the CYH2 allele. For the construction of the
aat1::HIS3MX6 strain, the AAT1 coding region was replaced by
the HIS3MX6 gene, which was amplified from plasmid pFA6a-
HIS3MX6 by PCR with 5′-TTTGAAAATTACTATCCGTTTTT-
CACTGCCGAAAGACTTGCGGATCCCCGGGTTAATTAA-3′
and 5′-TAAAAAAATAAAGACAAAGGTGAACTGTAAGGT-
GAAAAAAGAATTCGAGCTCGTTTAAAC-3′ primers and
used for transformation [20]. Successful integration was verified
using primers external to the genomic region deleted (5′-GACG-
ATAGCGGATTGAACGA-3′ and 5′-AGTTGGCTAGCGCTA-
GCTTT-3′). The Aat1 protein was tagged with three tandem
copies of the influenza virus HA (haemagglutinin) epitope
at the very C-terminus. The HA epitope tags for AAT1 was
amplified from the template pFA6a-3HA-HIS3MX6 as described
previously [20], using the following primers: 5′-TGAATCTC-
TTGAAGCAGTCTCGAAAATGGACAAACTCGCACGGAT-
CCCCGGGTTAATTAA-3′ and 5′-TAAAAAAATAAAGACA-
AAGGTGAACTGTAAGGTGAAAAAAGAATTCGAGCTCG-
TTTAAAC-3′. Successful integration was verified using the
external primers 5′-CGGAGTCAATGATTCGAACG-3′ and
5′-AGTTGGCTAGCGCTAGCTTT-3′. To generate a strain
carrying deletions in the mitochondrial DNA (herein called ρ0
strain), cells were grown for 24 h in defined medium (yeast
nitrogen base supplemented with the required amino acids, 2%
glucose and 200 μg/ml adenine) containing 10 μg/ml ethidium
bromide, 1/100 diluted in the same medium and treated for
another 24 h. Isolated clones were verified by genetic crossing
with ρ0 tester strains and plating on YPGly medium (1% yeast
extract, 2% Bacto peptone and 2% glycerol). Unless stated
all experiments were carried out in YPD medium (1% yeast
extract, 2% Bacto peptone and 2% D-glucose) at 30 ◦C. All
media were supplemented with 200 μg/ml adenine. For growth
under anaerobic conditions, the medium was supplemented with
30 mg/l ergosterol and 2 ml/l Tween 80 (Jacomex anaerobic
glove box; oxygen concentration below 5 p.p.m.).
Cell fractionation
Mitochondrial and extra-mitochondrial fractions were prepared
from stationary-phase cultured cells (D600 ∼4) in YPD medium.
Cell pellets were resuspended in ice-cold 50 mM potassium
phosphate buffer, pH 7.4, and 0.6 M sorbitol in the presence of
protease inhibitors (Roche), disrupted using glass beads (0.45–
0.55 mm diameter, Sartorius StedimBiotech) and centrifuged at
4 ◦C for 5 min at 1000 g, to remove glass beads, unbroken cells
and cell wall debris. The resulting supernatant was centrifuged
at 4 ◦C for 20 min at 10000 g. The supernatant corresponds to
the extra-mitochondrial fraction containing cytosolic, nuclear and
vacuolar proteins. The pellet containing the mitochondria was
rinsed twice and resuspended in the same buffer. The protein
content was determined using the Bradford assay and BSA as
the standard. The samples were frozen in a solid CO2/ethanol
bath and stored at − 80 ◦C. The quality of the mitochondrial and
extra-mitochondrial fractions was monitored by Western blotting
using the anti-porin antibody (mitochondrial protein) and anti-
(phosphoglycerate kinase) antibody (cytosolic protein); samples
that had less than 10% contamination were kept. However,
contamination with vacuolar proteins [monitored using anti-
(carboxypeptidase Y) antibody] can be as high as 20% in some
mitochondrial samples.
Enzymatic activities
Enzymatic activities were assayed spectrophotometrically at
340 nm using crude mitochondrial and extra-mitochondrial
fractions. To ensure an efficient disruption of mitochon-
drial membranes, assays were carried out in the presence of 0.1%
Triton X-100. Aspartate aminotransferase activity was measured
indirectly as the rate of the oxidation of NADH by malate
dehydrogenase. The reagent mixture contained 130 mM aspartate,
6.6 mM 2-oxoglutarate, 0.24 mM NADH, 5 units/ml malate dehy-
drogenase, 1.5 unit/ml LDH (lactate dehydrogenase) and 50 mM
potassium phosphate buffer, pH 7.4. Malate dehydrogenase was
assayed in 50 mM potassium phosphate buffer, pH 7.4,
0.6 mM oxaloacetate and 0.24 mM NADH. Activities
of alcohol dehydrogenase and G3PDH (glyceraldehyde-
3-phosphate dehydrogenase) were monitored by the rate of
NAD+ reduction. Alcohol dehydrogenase activity was assayed
in 0.1 M sodium pyrophosphate buffer, pH 9.2, 0.2 M ethanol
and 0.25 mM NAD+ , and G3PDH activity was assayed in
0.015 M sodium pyrophosphate buffer containing 0.03 M sodium
arsenate, pH 8.5, in the presence of 0.25 mM NAD, 3 mM DTT
(dithiothreitol) and 0.5 mM D, L-glyceraldehyde 3-phosphate.
Aconitase and succinate dehydrogenase activities were assayed
as described previously [21,22].
Immunoprecipitation and Western blotting
For immunoprecipitation, isolated mitochondria were lysed in
50 mM Hepes, pH 7.4, 150 mM NaCl, 0.5% NP-40 (Nonidet
c© The Authors Journal compilation c© 2012 Biochemical Society
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P40) and 10% glycerol in the presence of protease inhibitors
(Roche), incubated for 5 h at 4 ◦C with anti-acetylated lysine
antibody (Cell Signaling Technology) or anti-HA antibody (Santa
Cruz Biotechnology) and another 1 h of incubation with magnetic
beads coupled with Protein G (Adamtech). The beads were
washed three times with the lysis buffer and resuspended in
Laemmli sample buffer without 2-mercaptoethanol, boiled for
5 min and subjected to Western blotting. For Western blot
analysis, denaturated protein samples in Laemmli buffer were
separated by SDS/PAGE (10% gel) and the protein bands were
electrotransferred on to a Hybond nitrocellulose membrane (GE
Healthcare). Primary anti-HA (Santa Cruz Laboratory), anti-
(phosphoglycerate kinase) (Molecular Probes), anti-porin (Invit-
rogen) and anti-(acetylated lysine) (Cell Signaling Technology,
reference 9681 for Western blotting) monoclonal antibodies and
anti-(acetylated lysine) (Cell Signaling Technology, reference
9681 for immunoprecipitation) polyclonal antibody were detected
after incubation with peroxidase-conjugated secondary antibody,
with chemiluminescent substrate (Supersignal West from Pierce).
2D (two-dimensional) gel electrophoresis
The first dimension of 2D gel electrophoresis was performed
on a precast Immobiline DryStrip pH 3–11 NL, 7 cm (non-
linear immobilized pH 3–11 gradient gel; GE Healthcare) using
Multifor II System according to the manufacturer’s instructions.
The gels were loaded with 70 μg of mitochondrial protein
samples. Isoelectric focusing was followed by separation in a
10% polyacrylamide gel and Western blot analysis.
Metabolite analysis
The intracellular levels of NAD+ and NADH were measured
fluorimetrically (λex at 340 nm, λem at 460 nm) using yeast
alcohol dehydrogenase and LDH reactions respectively. To
prepare the whole-cell extracts, cells were harvested at the
exponential phase of growth (D600 ∼0.8), resuspended in 50 mM
Tris/HCl buffer, pH 7.4, and disrupted using glass beads. For
NAD+ analysis, samples were submitted to acidic extraction by
addition of perchloric acid to a final concentration of 0.2 M. The
precipitated proteins were removed by centrifugation and the
resulting supernatant was neutralized with KOH. NAD+ pools
were measured in 0.1 M pyrophosphate buffer, pH 9.2, in the
presence of 0.5% ethanol; 1 unit/ml alcohol dehydrogenase was
added and the increase in fluorescence intensity was recorded
until it reached a plateau. For NADH measurements, the same
samples were alkalized with KOH (0.05 M final concentration)
and incubated for 10 min at 60 ◦C. Samples (10–50 μl) were
added to 2 ml of reagent mixture (0.1 M triethanolamine/HCl,
pH 7.4, and 1.5 mM pyruvate). The conversion of NADH into
NAD+ was catalysed by 1 unit/ml LDH. CoA and acetyl-CoA
were analysed by reversed-phase HPLC (Shimadzu HPLC system
interfaced with the LabSolution software). Samples were injected
on to a Kromasil Eternity C18 column (length, 250 nm; internal
diameter, 4 mm; particle size, 5 μm) at 40 ◦C. The mobile phase
used for the separation consisted of two eluants: solvent A
was 20 mM sodium perchlorate buffer (pH 3.0), and solvent B
was acetonitrile. Compounds were separated by the following
discontinuous gradient at a flow rate of 1.5 ml/min: the initial
concentration of 5% in solvent B increased to 20% over
2.5 min and remained stable for 2.5 min; this was followed by
a decrease to 5% over the next 1 min, and the initial conditions
were then maintained for 5 min. The products were monitored
spectrophotometrically at 254 and 280 nm and quantified by
integration of the peak absorbance area, employing a calibration
curve established with various known concentrations of CoA and
acetyl-CoA. B6 vitamers were also determined by HPLC with
fluorescence detection as previously described [23].
Other techniques
Iron uptake was measured in microtitre plates. Overnight cultures
were diluted to a D600 of 0.2 in 10 ml of YPD medium,
grown for 4.5 h until the D600 reached 1.0, centrifuged and
resuspended in 2 ml of 50 mM citrate and 5% glucose. A 200 μl
aliquot was dispensed in microtitre plates in quadruplicate, 1 μM
[55Fe]ferrichrome was then added and the plate was incubated for
30 min at 30 ◦C. The cells were collected with a cell harvester
(Brandel) and washed on the filter before scintillation counting.
Cytochrome content and respiration were measured in cells
grown in YPRaf medium. Low-temperature absorption spectra
( − 191 ◦C) of whole cells were recorded as described previously
[19]. The respiratory activity of isolated mitochondria was meas-
ured with a 1 ml thermostatically controlled oxypolarographic cell
equipped with a Clark-type electrode. Oxygen consumption was
measured in 10 mM Tris/HCl, pH 6.8 (containing 0.65 M sorbitol,
0.36 mM EDTA, 10 mM KCl and 10 mM KH2PO4), saturated
with air at 30 ◦C (234 nmol/ml dissolved O2). The electron donors
for respiration were 1 mM NADH and 10 mM succinate.
RNA isolation and real-time quantitative PCR analysis
Total RNA for real-time quantitative PCR analysis was
extracted from stationary-phase cultured cells using the hot
phenol method as described previously [7] and purified
using Qiagen columns (RNeasy kit). Real-time quantitative
PCR analysis was performed as previously described using
ACT1 mRNA for normalization [24]. The AAT1 primer
sequences were 5′-TCCACCAGGATACGGTTCTC-3′ and 5′-C-
CACCCTAGACGGTCAAACA-3′. The relative expression in
yfh1/wt cells was calculated using the equation described
by Pfaffl [25]. The results reported were obtained from three
biological replicates and PCR runs were repeated twice.
Statistical analysis
All values are means +− S.D. for biological triplicates. All
experiments were repeated at least twice. Statistical analysis was
performed using a paired Student’s t test.
RESULTS
Mitochondrial aspartate aminotransferase activity is severely
reduced in yfh1 cells
Under aerobic and high-glucose conditions, S. cerevisiae cells
have a mixed metabolism relying on fermentation and respiration.
Several redox shuttles translocate electrons across the inner
mitochondrial membrane resulting in oxidation of NADH in
the cytosol and reduction of NAD+ in the mitochondria. To
determine how the low respiratory activity of yfh1 cells affects
the components of NADH shuttles, the activities of G3PDH,
alcohol dehydrogenase, malate dehydrogenase and aspartate
aminotransferase were measured in mitochondrial and extra-
mitochondrial (herein named cytosolic) fractions. No significant
difference was observed in the activities of cytosolic and
mitochondrial G3PDH in wild-type and yfh1 mutant cells
(Figure 1). A statistically significant (P < 0.001) increase in both
mitochondrial and cytosolic alcohol dehydrogenase activities was
detected in the yfh1 mutant compared with wild-type cells
(Figure 1). These results suggest that ethanol fermentation is
c© The Authors Journal compilation c© 2012 Biochemical Society
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Figure 1 Activity of NADH shuttle enzymes in yfh1, aat1 and wild-type mitochondria and cytosol
Activities of G3PDH, alcohol dehydrogenase, malate dehydrogenase and aspartate aminotransferase in mitochondrial and cytosolic fractions. Black bars, mitochondria; grey bars, cytosol. Results
are means +− S.D. (n = 3 or 4; ***P < 0.001).
induced in yfh1 cells, but not glycerol production. Malate
dehydrogenase activity was previously shown to be slightly
affected in yfh1 mutants [26]. Under the conditions used
in the present study, the malate dehydrogenase activities of
mitochondrial and cytosolic isoforms were decreased more than
2-fold in the yfh1 mutant compared with wild-type (Figure 1).
Although the cytosolic aspartate aminotransferase activity was
normal in yfh1 cells, the activity of the mitochondrial isoform
was less than 10% of the value determined for wild-type cells.
Indeed, a comparable residual activity was also detected in the
mutant deficient for the mitochondrial aspartate aminotransferase
(aat1) and corresponds to the contaminating cytosolic isoform
(Figure 1). These results show that the malate–aspartate shuttle
is severely affected in the yfh1 mutant due to the deficit in
mitochondrial aspartate aminotransferase activity and decreased
malate dehydrogenase activities.
As observed for yfh1, aat1 cells also showed increased
mitochondrial and cytosolic alcohol dehydrogenase activities
but no difference in G3PDH activity (Figure 1). This could be
explained by increased ethanol fermentation in yfh1 and aat1
cells to compensate for reduced respiration (see below for
aat1 results). The decrease in cytosolic malate dehydrogenase
activity in yfh1 cells could be due to the lack of Aat1 since
the same decrease in activity was also observed in aat1
cells (Figure 1). However, regarding the mitochondrial malate
dehydrogenase isoform, a decrease in activity was only observed
in yfh1 cells and could result from a general decline in the
oxidative phosphorylation and the tricarboxylic acid cycle or to
post-translational modifications (see below).
Influence of deficiency in iron–sulfur clusters, loss of
mitochondrial DNA and oxidative stress in mitochondrial aspartate
aminotransferase activity
Major phenotypes of yeast yfh1 include deficiency in iron–
sulfur clusters, loss of mitochondrial DNA and sensitivity to
oxidants. Therefore we tested whether these conditions could
result in decreased Aat1 activity. Indeed, cells deficient in cysteine
desulfurase activity (essential for iron–sulfur cluster biosynthesis;
nfs1-14 mutant) and cells lacking complete mitochondrial
genome (ρ0 mutant) showed reduced Aat1 activity, but no
significant difference in the activity of the cytosolic isoform
(Figure 2A). Treatment of wild-type cells for 6 h with 2 mM
H2O2, 2 mM paraquat or 0.4 mM menadione did not result in
any change in Aat1 activity (results not shown). In addition,
under anaerobic conditions, yfh1 and wild-type cells showed
identical activities of cytosolic and mitochondrial aspartate
aminotransferase isoforms (Figure 2B). In conclusion, the reduced
Aat1 activity could be a secondary effect of iron–sulfur cluster
deficiency, loss of mitochondrial DNA and aerobic metabolism in
yfh1 cells.
Loss of mitochondrial aspartate aminotransferase causes
disruption of iron metabolism and reduced respiratory activity
To understand what the cellular effects of Aat1 deficiency are,
we analysed in detail aat1 mutant phenotypes. Cellular iron
uptake was measured using [55Fe]ferrichrome which is imported
by the Arn1 transporter and is a bona fide marker of the status
of Aft1-regulated genes [27]. A small, but significant, increase
(1.8-fold; P < 0.001) in cellular iron uptake was detected in
aat1 compared with wild-type cells (Figure 3A). Activities of
aconitase and succinate dehydrogenase, which are iron–sulfur
cluster-dependent enzymes, were also significantly decreased in
aat1 mitochondria (Figure 3B). Cytochrome content, detected
by low-temperature spectra, was also altered in the aat1
mutant compared with wild-type (Figure 3C). The spectrum was
similar to that observed for ρ0 mutants showing low content
of cytochromes a, a3 and b. However, no increase in loss of
mitochondrial DNA was observed in the aat1 mutant compared
with wild-type (results not shown). In addition, a clear decrease
c© The Authors Journal compilation c© 2012 Biochemical Society
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Figure 2 Deficiency in iron–sulfur clusters and loss of mitochondrial DNA
cause a decrease in the activity of mitochondrial aspartate aminotransferase
Activities of mitochondrial and cytosolic aspartate aminotransferase in (A) ρ0 and nfs1
mutants and (B) anaerobic yfh1 and wild-type cells. Results are means +− S.D. (n = 2–4;
***P < 0.001).
in oxygen uptake was observed, using 1 mM NADH and 10 mM
succinate as substrates, in aat1 compared with wild-type cells
(Figure 3D). The reduced respiratory capacity was also evident
from the poor growth of aat1 cells in rich media containing
glycerol as the sole carbon source (Figure 3E). However, the
aat1 mutant did not show any sensitivity to H2O2 (Figure 3E).
These results show that deficiency in Aat1 causes a reduction
in respiration and disturbs mitochondrial iron metabolism, as
evidenced by decreased activity of iron–sulfur cluster enzymes,
loss of cytochromes and increased cellular iron content. As
expected, these phenotypes are milder than those observed for
yfh1 cells (Figure 3), but suggest that secondary Aat1 deficiency
could exacerbate the respiratory defect in these cells. However,
a striking observation in aat1 cells was the retention of
mitochondrial DNA and resistance to oxidative stress, which
are generally not conserved in yeast mutants that show affected
mitochondrial functions.
NAD+ /NADH pools in yfh1 and aat1 cells
The levels of total intracellular NAD+ and NADH were measured
in exponential (D600≈1) yfh1 and aat1 cells, (Table 1).
Unexpectedly, in yfh1 cells, an increase of more than 2-fold
was detected in both NAD+ and NADH levels. This could be a
cellular response to the state of constitutive oxidative stress in
mutant cells. Two studies reported that treatment of wild-type
cells with H2O2 induced an increase in total NAD+ + NADH
levels [28,29]. In addition, the salvage pathway appears to be
necessary for this increase under oxidative stress conditions
[29]. Another possibility is related to phosphate signalling.
Recent findings uncovered a link between the PHO (phosphate-
responsive signalling) pathway and NAD+ metabolic pathways
mediated by nicotinamide riboside [30]. Wild-type cells grown
in low-phosphate medium presented a significant increase in
the level of nicotinamide riboside, an NAD+ precursor. This
is in agreement with our previous results showing a deficit
in soluble phosphate in yfh1 cells due to precipitation in
the mitochondria and deregulation of the PHO pathway [24].
Another possibility could be that NAD+ /NADH utilization
pathways are lowered in mutant cells. One of these pathways is
the synthesis of NADP+ /NADPH from NAD+ /NADH. Indeed,
yfh1 cells have been shown to have a 2.4-fold reduction in
total NADP+ /NADPH levels [7]. Altogether, oxidative stress,
iron phosphate precipitation and/or reduced NADP levels could
contribute to the increased levels of NAD observed in yfh1
cells. In the case of the aat1 mutant, no significant difference
was observed in NAD+ and NADH levels compared with wild-
type cells (Table 1). This is consistent with the observation
that deletion of the Ndt1- and Ndt2-encoding genes did not
result in a significant difference in the cellular nucleotide levels
in high-glucose media [31]. However, a displacement in the
distribution of NAD+ was observed, with lower cytosolic and
higher mitochondrial levels. A reduction in the NAD+ /NADH
ratio was detected in both yfh1 and aat1 mutants and reflects
the poor respiratory activity observed in these strains.
Mitochondrial aspartate aminotransferase is deacetylated inyfh1
We addressed the question of why Aat1 activity is inhibited
in yfh1 cells. Transcription of the AAT1 gene was 4-fold
decreased in yfh1 compared with wild-type cells (yfh1/wt
ratio, 0.25 +− 0.09). Strains were then constructed containing the
Aat1 protein HA-tagged at the C-terminus in the wild-type and
yfh1 context. In these strains, Aat1 activities were not modified
compared with non-tagged wild-type and yfh1 cells indicating
that the Aat1–HA enzyme remained functional (Figure 4A).
Surprisingly, no considerable reduction in the amount of protein
level was detected after Western blotting using an anti-HA
antibody (Figure 4B). Moreover, a single distinct band was visible
in Western blots excluding several protein modifications that
result in a mass change detectable by this technique. We tested
whether the oxidation/reduction state of Aat1 protein could be
involved by treating the mitochondrial extracts for 10 min with
500 μM DTT before activity measurements; no change in the
activities of Aat1 was observed in wild-type and yfh1 cells
(results not shown).
Aspartate aminotransferases are PLP (pyridoxal 5′-phosphate)-
containing enzymes; we therefore investigated whether the
cofactor was misplaced or lacking in yfh1 cells. Vitamin
B6 refers to a group of six compounds, PL (pyridoxal),
PN (pyridoxine), PM (pyridoxamine) and their respective
5′-phosphorylated derivatives. PLP is the biochemically
active cofactor that can readily be synthesized from the other
five vitamers by the salvage pathway [32]. In vitro incubation
of mitochondrial extracts with 0.5 mM PLP before enzymatic
activity determination did not lead to an increase in Aat1 activity
(results not shown). In addition, no significant difference was
observed in PLP levels determined by HPLC between yfh1
and wild-type cells (Figure 5). However, mitochondrial pools
of PL, PN and PM were reduced, although not significantly, in
yfh1 compared with wild-type cells. PM has also an antioxidant
function in the cell [33]. Possibly this decrease is the consequence
of the constitutive oxidative state condition of yfh1 cells.
Nevertheless cytosolic and mitochondrial PLP pools were not
affected in yfh1 cells, suggesting that inactivation of the enzyme
was not due to lack of cofactor.
The Aat1 profile obtained using 2D gel electrophoresis revealed
the presence of additional isoforms in the wild-type mitochondria
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Figure 3 Iron metabolism, respiration and oxidative stress-related phenotypes of aat1 cells
(A) Iron uptake from 1 μM ferrichrome. (B) Mitochondrial aconitase and succinate dehydrogenase activities. (C) Cytochrome content (low-temperature spectra). (D) Mitochondrial oxygen uptake
using 1 mM NADH and 10 mM succinate as respiratory substrates. (E) Growth on glycerol substrate and sensitivity to 1 mM H2O2. Five-fold dilutions of D600 = 3.0 cell suspensions were spotted
on to different media and incubated for 3–4 days at 30◦C. Results are means +− S.D. (n = 3; **P < 0.01, ***P < 0.001) or one representative experiment from three performed.
Table 1 Intracellular NAD levels in wild-type, yfh1 and aat1 cells
Results are means +− S.D. (n = 3; *P < 0.05; **P < 0.01; ***P < 0.001).
Strain
NAD+ (nmol/mg of
protein) NADH (nmol/mg of protein) NAD+ /NADH ratio
Total
WT 23.1 +− 2.00 11.2 +− 0.59 2.1 +− 0.06
yfh1 48.0 +− 5.75** 33.7 +− 4.35*** 1.4 +− 0.03***
aat1 20.2 +− 1.00 13.0 +− 1.70 1.6 +− 0.24*
Cytosol
WT 24.0 +− 0.84 29.9 +− 1.72 0.8 +− 0.01
yfh1 36.4 +− 2.27*** 54.4 +− 1.53*** 0.7 +− 0.03***
aat1 16.7 +− 0.86** 31.7 +− 1.40 0.5 +− 0.05***
Mitochondria
WT 4.1 +− 0.36 <0.5 >10
yfh1 5.0 +− 0.30* <0.5 >10
aat1 5.6 +− 0.49* <0.5 >10
Figure 4 Post-translational inactivation of Aat1 in yfh1 cells
(A) Activity of Aat1–HA in wild-type and mutant mitochondria. (B) Proteins from whole cells and
mitochondria were analysed by immunoblotting using anti-HA, anti-(phosphoglycerate kinase)
(PGK) and anti-porin antibodies.
Figure 5 Vitamin B6 pools in yfh1 and wild-type cells
PLP, PL, PN and PM levels were determined by HPLC in mitochondrial and cytosolic fractions.
Results are means +− S.D. (n = 3).
with decreased pI (Figure 6A), which are compatible with
protein modification by phosphorylation or acetylation. Treatment
of wild-type and yfh1 mitochondrial samples with alkaline
phosphatase did not reveal any Aat1 pattern change in
SDS/PAGE or 2D gel electrophoresis (results not shown).
We then tested for acetylation/deacetylation modifications. The
human mitochondrial aspartate aminotransferase (Got2) has
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Figure 6 Mitochondrial aspartate aminotransferase is deacetylated in
yfh1 cells
(A) Protein separation from mitochondrial fraction by 2D gel electrophoresis and
immunodetection using anti-HA antibody. (B) Mitochondrial acetyl proteome detected by
Western blotting using an anti-(acetylated lysine) antibody. (C) Mitochondrial proteins were
immunoprecipitated using anti-(acetylated lysine) antibody and Aat1 was immunodetected
using anti-HA antibody.
eight putative acetylation sites (Lys73, Lys90, Lys150, Lys159,
Lys234, Lys296, Lys396 and Lys404; http://www.phosida.com; [34]).
Although no acetylation site is predicted for the Aat1 amino
acid sequence, Got2 Lys73 is conserved in Aat1 (Lys60).
Recently, Morselli et al. [35] showed that treatment of
human colon carcinoma HCT 116 cells with resveratrol and
spermidine elicit deacetylation of Got2 Lys73. In addition,
Got2 has also been found to be acetylated in human liver
tissue (Lys150 and Lys309) [36]. It is thus possible that the
acetylation status of Aat1 is modified in yfh1 cells. The
mitochondrial proteome of yfh1 samples showed a substantial
reduction in the amount of acetylated proteins as evidenced
by detection in Western blots using anti-(acetylated lysine)
antibodies (Figure 6B). Protein acetylation and deacetylation
is catalysed by protein lysine acetyltransferases (formerly
termed histone acetyltransferases) and protein lysine deacetylases
(formerly termed histone deacetylases) respectively [37]. Protein
acetyltransferases transfer an acetyl group from acetyl-CoA to
form ε-N-acetyl-lysine. In agreement with the observation that
mitochondrial proteins of yfh1 cells are less acetylated, the
mitochondrial levels of acetyl-CoA and CoA were reduced
in this mutant compared with wild-type (CoA, 0.07 +− 0.005
nmol/mg of protein in yfh1 and 0.11 +− 0.014 nmol/mg
of protein in wild-type; acetyl-CoA, 1.54 +− 0.111 pmol/mg of
protein in yfh1 and 2.09 +− 0.293 pmol/mg of protein in
wild-type). Immunoprecipitation of mitochondrial acetylated
proteins followed by detection of Aat1–HA using an anti-
HA antibody revealed that the amount of protein detected
in yfh1 was considerably reduced compared with wild-type
(Figure 6C). These results suggest that Aat1 was subjected to
post-translational modifications (deacetylation) that may possibly
lead to inactivation.
DISCUSSION
The regulation of cellular NAD and NADP pools is essential
for energy metabolism, regulation of antioxidant capacity and
generation of ROS, which correspond to major functions
affected in frataxin-deficient cells. In the present study, we
show that, although the NAD+ /NADH ratio is decreased, the
total NAD+ + NADH level is higher in yfh1 compared with
wild-type cells. This could result from oxidative stress state,
phosphate deficiency and/or Aat1 inactivation. Increased overall
cellular concentration of NAD is in apparent contradiction with
the respiratory defect observed in the yfh1 mutant. However, it
was observed that an increase or a decrease in mitochondrial NAD
content by modulation of the expression of Ndt1/2 carriers results
in reduced cellular ATP content under full respiratory conditions
[31]. In the conditions used in the present study of high-glucose
media and aerobiosis, the metabolism of yfh1 cells is shifted
to alcohol fermentation. The alcohol dehydrogenase shuttle is
activated in yfh1 possibly to compensate for the blockage of
the tricarboxylic acid cycle due to loss of aconitase and succinate
dehydrogenase activities, reduced malate dehydrogenase activity
and inhibition of the malate–aspartate shuttle.
The S. cerevisiae electron transport chain lacks complex I.
As an alternative, an inner mitochondrial membrane NADH
dehydrogenase, Ndi1, and two external NADH dehydrogenases,
Nde1 and Nde2, transfer electrons directly from the matrix
and cytosolic NADH to ubiquinone. Under aerobic conditions,
external NADH dehydrogenases and the glycerol 3-phosphate
shuttle are the most important mechanisms for mitochondrial
oxidation of cytosolic NADH [13,14]. For this reason, the
physiological significance of the malate–aspartate shuttle in yeast
metabolism has long been questioned. The identification of
the mitochondrial aspartate/glutamate transporter Agc1 provided
strong evidence for the existence of this shuttle [15]. Later,
the mitochondrial components of the malate–aspartate shuttle
were shown to play a major role in calorie restriction-induced
lifespan extension in yeast [16]. Our results showing the reduced
respiratory activity of aat1 mutant further demonstrate the
importance of the malate–aspartate shuttle in energy metabolism
in yeast.
The finding that the malate–aspartate shuttle is inhibited
in yfh1 cells raises the question of whether its activity is
also altered in frataxin-deficient human cells. The malate–
aspartate shuttle is quantitatively the most important in the
brain, in pancreatic β-cells and in almost all vertebrate
tissues [38]. This redox shuttle is composed of cytosolic
and mitochondrial aspartate aminotransferases and malate
dehydrogenases, the malate 2-oxoglutarate carrier and two
calcium-sensitive aspartate/glutamate carriers, Aralar1 (primarily
expressed in skeletal muscle, brain and pancreatic β-cells) and
citrin (primarily expressed in liver and kidneys). In pancreatic
β-cells, coupling of glycolysis to the TCA cycle and electron
transport chain is necessary for glucose-induced insulin secretion.
It is thus not surprising that the NADH redox shuttles play
a significant role in the regulation of insulin secretion [38].
Overexpression of Aralar1 enhances mitochondrial metabolism
and insulin secretion [39]. Inversely, disruption of the glycerol
3-phosphate and the malate–aspartate shuttles in mice lead to
suppression of glucose-induced increase in NADH and ATP and
insulin secretion [40]. A high percentage of FA patients present
Type 2 diabetes involving deterioration of the capacity of insulin
release and action [1]. This is a late clinical feature, generally
diagnosed after onset of neurological disability [41]. It is possible
that the malate–aspartate redox shuttle is affected in pancreatic
β-cells from patients contributing to the emergence of diabetes.
Reversible lysine acetylation is conserved from prokaryotes
to humans [42]. This post-translational modification has been
extensively studied for histones, where it plays a key role in the
regulation of chromatin dynamics and gene expression. Proteomic
analysis using several mammalian cell lines, mouse and human
liver and bacteria revealed that not only are nuclear proteins
acetylated, but numerous cytosolic and mitochondrial proteins are
also acetylated [35,36,42–45]. In particular, metabolic enzymes
are extensively acetylated suggesting that this post-translational
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modification has a potential regulatory role. Indeed, alterations
in the availability of extracellular nutrients induce variations in
the degree of enzyme acetylation [36]. Acetylated enzymes belong
to different pathways such as glycolysis, gluconeogenesis, the
TCA cycle, fatty acid oxidation, glycogen metabolism, the urea
cycle, amino acid metabolism and oxidative phosphorylation
[37]. In human liver, all enzymes of the TCA cycle and a
large proportion of glycolysis enzymes are acetylated [36]. The
relationship between acetylation and activity has only been
investigated in a small number of enzymes, and it appears
that acetylation can affect protein stability and activity, by
either increasing or decreasing it [36,44]. Mitochondrial malate
dehydrogenase participates in the TCA cycle and the malate–
aspartate NADH shuttle. In human liver, this enzyme has
four acetylated lysines residues and activity was increased by
acetylation [36]. Excluding reports concerning chromatin and
gene transcription, nothing is known on the subject of lysine
acetylation of yeast proteins. However, since metabolic enzymes
of organisms as distant as bacteria and human are acetylated, it
is expected that the metabolism of yeast cells is also regulated
by acetylation/deacetylation. A general decrease in acetylation
was observed for mitochondrial proteins of molecular mass
higher than 25 kDa in yfh1 cells. It is possible that a decrease
in acetylation causes a reduction in malate dehydrogenase
activity. Aspartate aminotransferase was also found to be active
only in wild-type mitochondria where the acetylation level
is high. It is tempting to speculate that the mitochondrial
components of the malate–aspartate NADH shuttle are regulated
by acetylation/deacetylation.
In yeast mitochondria, nothing is known about the
enzymes responsible for the lysine-acetyltransferase and lysine-
deacetylation activities. In mammalian cells, several members
of the SIRT NAD+ -dependent protein deacetylase family are
localized in the mitochondria (SIRT3/4/5) [46]. Results obtained
from deletion of the Sirt3 gene in mouse revealed a global
alteration of protein acetylation, thus suggesting that SIRT3 is
a major deacetylase in the mitochondria [47]. SIRTs and the Sir2
yeast homologue use NAD+ as an obligatory substrate in the
deacetylation reaction. It is proposed that a high ratio of cellular
NAD+ /NADH activates Sir2 during calorie restriction as a result
of increased respiratory activity [48]. A similar proposition
has been made for mammalian SIRTs [37]. In yfh1 cells, a
decrease in the NAD+ /NADH ratio is observed in addition to
hypoacetylation of mitochondrial proteins. This is not compatible
with what is known about the regulation of deacetylases activity.
Another hypothesis is that acetyltransferase activity is reduced in
yfh1; this would be consistent with the metabolic shift towards
alcohol fermentation and reduction of acetyl-CoA levels and the
TCA cycle.
Frataxin-deficient cells from all eukaryotic organisms studied
have pleiotropic phenotypes [6]. It is recognized that assembly
of iron–sulfur clusters is the primary function affected as well
as the contribution of oxidative stress hypersensitivity and
disruption of iron homoeostasis. Post-translational modifications
of proteins allow regulation of important cellular functions that
could strengthen or generate new phenotypes in frataxin-deficient
cells. In the present study, we found that mitochondrial protein
acetylation is modified in the yfh1 mutant, which could result
in deacetylation of Aat1 and its inactivation, exacerbating the
respiratory deficiency. Other protein modifications have been
observed in frataxin-deficient cells. The glutathionylation of actin
alters cytoskeletal dynamics impairing the induction of the Nrf2-
dependent Phase II antioxidant pathway in fibroblasts from FA
patients [49,50]. These results draw attention to the importance
of post-translational protein modifications in frataxin-deficient
cells and the need to expand our knowledge in this area to better
understand the physiopathology of FA.
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